Robert J. Soiffer, M.D.

Dana-Farber Cancer Institute

Disclosure(s): CSL Behring: Advisor/Consultant; Gilead: Career Chair Development Award; Jasper Therapeutics: Advisor/Consultant; Jazz Pharmaceuticals: Advisor/Consultant; Juno (BMS): DSMB; Kiadis: Board Member; Vor: Advisor/Consultant

Poster(s):

• 2098 - Cytomegalovirus (CMV) Infection Following Hematopoietic Cell Transplantation (HCT) with Post-transplant Cyclophosphamide (PTCy): Outcomes in Haploidentical versus Matched or Mismatched Unrelated Donor (MUD/MMURD) Allografts
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET